Developing an Intervention to Prevent Visceral Adipose Tissue Accumulation

Sponsor
Rush University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT01778712
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
71
1
1
46
1.5

Study Details

Study Description

Brief Summary

The aim of this study is to develop an intervention that will produce a sustained improvement in physical activity and chronic stress as a means to slow the menopause-related accumulation of visceral adipose tissue in mid-life women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Multi-level intervention
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
71 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Developing an Intervention to Prevent Visceral Adipose Tissue Accumulation in Premenopausal Women: WISHfit Phase 2
Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
Feb 1, 2016
Actual Study Completion Date :
Feb 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Multi-level intervention

Behavioral: Multi-level intervention
The development of a lifestyle program intended to intervene on the individual, social network and community over two years
Other Names:
  • Lifestyle program
  • Outcome Measures

    Primary Outcome Measures

    1. Change in visceral adipose tissue, as measured by CT [At two years from baseline]

      <4% gain in visceral adipose tissue over a 2-year period

    Secondary Outcome Measures

    1. Effects of the multi-level intervention [At two years from baseline]

      Physical activity as assessed by accelerometer (min/week of >= 3 MET)

    2. Effects of the multi-level intervention [At two years from baseline]

      Proportion or participants meeting a 120 min/week physical activity goal

    3. Effects of the multi-level intervention [At two years from baseline]

      Vitality subscale of the SF36 questionnaire

    4. Effects of the multi-level intervention [At two years from baseline]

      Assess Dietary changes (vegetable, protein, fat, sugar-sweetened beverage consumption)

    5. Effects of the multi-level intervention [At two years from baseline]

      Assess Perceived stress

    6. Effects of the multi-level intervention [At two years from baseline]

      Assess Perceived social support

    7. Effects of the multi-level intervention [At two years from baseline]

      Knowledge of menopausal effects on health in the target community, as assessed by the "man on the street" survey

    Other Outcome Measures

    1. Change in body composition [At two years from baseline]

      Change in waist girth and BMI Subcutaneous and visceral adipose tissue as measured by CT Body composition as measured by dual energy X-ray absorptiometry (fat, lean mass)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    42 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Resident of the Beverly or Morgan Park neighborhood of Chicago or contiguous neighborhoods

    • Female

    • African American or Caucasian

    • Age 42 years or older

    • Intact uterus, at least one functioning ovary, at least one menstrual period in the last 12 months prior to screening.

    • Sufficient motivation level to make lifestyle changes, as determined by WISHFIT staff.

    Exclusion Criteria:
    • Hysterectomy

    • Physical activity > 90 min per week

    • Metabolic conditions or use of medications that affect weight of visceral adipose tissue (diabetes, acquired immune deficiency syndrome, weight > 300 lbs)

    • Presence or history of major psychiatric comorbidity (i.e. dementia, schizophrenia, bipolar disorder, alcohol/drug addiction) in the last 6 months

    • History of inpatient mental health treatment

    • Currently prescribed antipsychotic medication

    • History of hallucinations or bizarre thoughts

    • Current pregnancy

    • Has been told by a physician that it is unsafe to engage in physical activity

    • An illness expected to limit functional status or life expectancy, including: heart failure, recent heart attack, liver cirrhosis, kidney failure, oncologic conditions, history or heart surgery, angioplasty or artery stenting.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Preventive Medicine, Rush University Medical Center Chicago Illinois United States 60612

    Sponsors and Collaborators

    • Rush University Medical Center
    • National Heart, Lung, and Blood Institute (NHLBI)

    Investigators

    • Principal Investigator: Lynda H. Powell, PhD, MEd, Rush University Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Lynda Powell, PhD, MEd, PhD, MEd, Rush University Medical Center
    ClinicalTrials.gov Identifier:
    NCT01778712
    Other Study ID Numbers:
    • 09090108
    • 5U01HL097894-03
    First Posted:
    Jan 29, 2013
    Last Update Posted:
    Apr 27, 2016
    Last Verified:
    Apr 1, 2016

    Study Results

    No Results Posted as of Apr 27, 2016